Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants

“The high costs associated with these products will require those administering these vaccines, such as pediatricians, family physicians, hospitals, and health systems, to be meticulous in their ordering, inventory, and billing management practices to make them feasible to deliver in real-world settings,” Sean T. O’Leary, from the University of Colorado School of Medicine/Children’s Hospital Colorado in Aurora, writes in an accompanying editorial.